Comparative studies of two-times-daily versus three-times-daily indinavir in combination with zidovudine and lamivudine.

Haas, D W

Comparative studies of two-times-daily versus three-times-daily indinavir in combination with zidovudine and lamivudine. [electronic resource] - AIDS (London, England) Sep 2000 - 1973-8 p. digital

Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

0269-9370

10.1097/00002030-200009080-00013 doi


Adult
Anti-HIV Agents--adverse effects
Antiretroviral Therapy, Highly Active
CD4 Lymphocyte Count
Drug Administration Schedule
HIV Infections--drug therapy
HIV-1--isolation & purification
Humans
Indinavir--administration & dosage
Lamivudine--adverse effects
Pilot Projects
RNA, Viral--blood
Reverse Transcriptase Inhibitors--adverse effects
Treatment Outcome
Viral Load
Zidovudine--adverse effects